Severe mitral regurgitation can make everyday activity increasingly difficult. Patients may become breathless while walking, feel unusually tired, notice swelling in the legs or experience repeated episodes of heart failure. When medicines alone are not enough and the valve leak is clinically important, treatment may need to focus on the mitral valve itself.
For selected patients, MitraClip offers a catheter-based way to reduce mitral regurgitation without conventional open-heart surgery. The treatment is performed using transcatheter edge-to-edge repair, or TEER.
Patients exploring MitraClip in Mumbai should understand that the procedure is not simply an alternative chosen because it is less invasive. The valve anatomy, cause of regurgitation, surgical risk, heart function and expected clinical benefit all need to support the decision.
What Is MitraClip?
MitraClip is a small device designed to grasp the leaflets of the mitral valve. In mitral regurgitation, the leaflets do not meet effectively, so blood leaks backward from the left ventricle into the left atrium.
During TEER, the clip brings selected parts of the leaflets together. This creates a double-opening configuration that can improve valve closure and reduce backward flow.
The native valve remains in place. Unlike valve replacement, the procedure modifies how the existing leaflets close.
Who May Be Considered for TEER?
Patient selection starts with determining the type and severity of mitral regurgitation.
Primary mitral regurgitation results from a structural problem in the valve itself, such as prolapse or a flail leaflet. Surgery remains an important treatment for many patients with primary disease, particularly when a durable repair can be achieved with acceptable surgical risk.
TEER may be considered when severe primary regurgitation requires treatment but surgery carries high or prohibitive risk and the valve anatomy is suitable.
Secondary mitral regurgitation occurs because the left ventricle or atrium changes shape. For these patients, treatment of heart failure is central. TEER may be considered when severe regurgitation and symptoms continue despite appropriate medical therapy and other indicated treatment.
Why Detailed Echocardiography Is Essential
MitraClip planning depends heavily on echocardiography. A standard transthoracic echo measures the severity of the leak, ventricular function and pulmonary pressures.
Transoesophageal echocardiography provides more detailed views of the mitral leaflets. The team studies the location of the leak, leaflet length, calcification, valve area and the ability of the leaflets to be grasped securely.
This imaging helps answer two questions: can a clip technically be placed, and is it likely to reduce the regurgitation without making the valve too narrow?
How the TEER Procedure Is Performed
During the TEER procedure, a catheter is typically introduced through the femoral vein in the groin. The system is guided to the right atrium.
The operator creates a controlled opening through the atrial septum to reach the left atrium. From there, the clip-delivery system is positioned above the mitral valve.
Fluoroscopy and transoesophageal echo guide every major step. The clip is opened, aligned with the regurgitant jet and advanced toward the leaflets. Once the leaflets are captured, the team checks whether the leak has been reduced.
If the result is satisfactory and the valve pressure remains acceptable, the clip is released. Some patients may require an additional device.
What Are the Main Benefits?
For suitable patients, the most important benefit is reduction of significant mitral regurgitation. This may improve breathlessness, exercise tolerance and quality of life.
Because the procedure is catheter based, there is no conventional sternotomy. This can reduce the physical burden of treatment for elderly, frail or medically complex patients who may not tolerate open-heart surgery well.
The benefit is greatest when the valve leak is a major cause of the patient’s symptoms and the underlying heart condition is being treated appropriately.
What Risks Should Be Discussed?
TEER can involve bleeding, vascular complications, stroke, infection, rhythm problems or complications from crossing the atrial septum.
The clip may not reduce regurgitation sufficiently, or the valve may become too narrow if too much leaflet tissue is approximated. Device-related problems are uncommon but possible.
A detailed Heart Team discussion should explain these risks in relation to the patient’s own anatomy and medical condition rather than relying only on general statistics.
Recovery After MitraClip
Patients are monitored after the procedure for bleeding, heart rhythm and clinical stability. Echocardiography is used to confirm the reduction in regurgitation and ensure that the mitral valve is not excessively narrowed.
Hospital stay is often shorter than after open-heart surgery when recovery is uncomplicated. Patients may begin mobilising relatively early, but the exact timing depends on age and health.
Instructions at discharge should cover medicines, access-site care, activity and warning signs.
Why Follow-Up Still Matters
MitraClip treats the valve leak, but it does not remove the need for long-term cardiac care. Patients with secondary mitral regurgitation usually continue heart-failure therapy after TEER.
Follow-up echocardiography helps monitor residual regurgitation, valve gradients and heart function. Medication can be adjusted as symptoms and blood pressure change.
Working with an experienced cardiologist in Mumbai is valuable because symptom improvement after the procedure should be assessed together with the underlying cardiac condition.
Choosing a MitraClip Programme
Patients should look for a programme with structural heart expertise, advanced echocardiography and a multidisciplinary Heart Team. The centre should be able to discuss surgery, TEER and medical therapy objectively.
Experience is important not only for clip placement but also for deciding when not to perform the procedure.
The Bottom Line
MitraClip can provide a less-invasive treatment for selected patients with severe mitral regurgitation. Good results depend on choosing the right patient, confirming suitable anatomy, performing the procedure with precise imaging and continuing appropriate cardiac treatment afterward.
For patients considering MitraClip in Mumbai, the key is a complete evaluation rather than simply finding a centre that offers the device. A careful Heart Team assessment can determine whether TEER is likely to meaningfully reduce symptoms and provide an appropriate alternative to mitral valve surgery.
